Last reviewed · How we verify
Artefill dermal filler
At a glance
| Generic name | Artefill dermal filler |
|---|---|
| Also known as | polymethylmethacrylate (PMMA) |
| Sponsor | Gerald Pierone, Jr. M.D. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Feasibility Study for Fibroblast Autologous Skin Grafts (PHASE2)
- Artefill for the Treatment of HIV-associated Facial Lipoatrophy (PHASE1)
- Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Artefill dermal filler CI brief — competitive landscape report
- Artefill dermal filler updates RSS · CI watch RSS
- Gerald Pierone, Jr. M.D. portfolio CI